PATENT CLAIM ANALYSIS

Application Number: 16005349
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["544", "101000"]

Abstract:
The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.

Claim (Index 5):
The combination according to  claim 2  wherein the at least one further antibacterial compound (ii) is selected from the following compounds:\n \u00df-lactams:\n penems including carba-, thio-, and oxapenems such as imipenem, meropenem, ertapenem, faropenem, biapenem; \n cephalosporines such as cefazolin, cefepime, cefotaxime, cefoxitine, ceftaroline, ceftazidime, ceftobiprole, ceftriaxone, cefuroxime and cephalexine; \n monobactames such as aztreonam, BAL30072; \n penicillines such as penicillin G (benzylpenicillin), penicillin V (phenoxymethylpenicillin); acylaminopenicillines such as piperacillin, mezlocillin, azlocillin; aminopenicillines such as ampicillin, amoxicillin; isoxazolylpenicillines such as oxacillin, cloxacillin, dicloxacillin, flucloxacillin; methicillin; sultamicillin; ticarcillin, carbenicillin, temocillin; \n combinations of \u00df-lactams with a \u00df-lactamase inhibitor such as clavulanic acid+amoxicillin, sulbactam+ampicillin, tazobactam+piperacillin, ticarcillin+clavulanate, ceftazidime+avibactam, ceftaroline+avibactam, imipenem+MX-7655, biapenem+RPX7009, aztreonam+avibactam; \n \n fosfomycin; \n fosmidomycin; \n glycopeptides such as teicoplanin, vancomycin; \n lipopeptides such as daptomycin; \n lipoglycopeptides such as telavancin, oritavancin, dalbavancin; \n other agents active against Gram-positive bacteria such as GSK-1322322, AFN-1252, MUT-056399; \n polypeptides such as bacitracin, colistin, gramicidin, polymyxin B, tyrothricin; \n other membrane-acting agents such as brilicidin, POL7080, ACHN-975; \n aminoglykosides such as amikacin, gentamicin, kanamycin, neomycin, netilmicin, streptomycin, tobramycin; \n chloramphenicol, thiamphenicol; \n fusidic acid; \n macrolides such as azithromycin, clarithromycin, erythromycin, roxythromycin, ketolides such as cethromycin, narbomycin, telithromycin, solithromycin; \n lincosamides such as clindamycin, lincomycin; \n Streptogramines such as dalfopristin, quinupristin; \n polyketides \n oxazolidinones such as linezolid, tedizolid, radezolid; \n tetracyclines such as doxycyclin, minocyclin, tetracyclin, oxytetracyclin; \n glycylcyclines such as tigecyclin, omadacycline; \n type II topopisomerase inhibitors:\n quinolones (especially fluoroquinolones) such as norfloxacin, enoxacin, ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, grepafloxacin, moxifloxacin, delafloxacin, finafloxacin, nemonoxacin, zabofloxacin, ozenoxacin, chinfloxacin, JNJ-Q2, DS-8587, KPI-10, GSK2140944, ACH-702; \n coumarins such as novobiocin, clorobiocin, coumermycin A; \n \n nitroimidazoles such as metronidazole, tinidazole, ornidazole, nimorazole; \n folic acid agonists:\n sulfonamides such as sulfadiazin, sulfadoxin, sulfamethoxazole, sulfasalazin; \n diaminopyrimidines such as pyrimethamin, trimethoprim; \n \n ansamycines:\n rifamycines such as rifampicin,rifabutin, rifapentin, rifamixin; \n \n additional classes:\n pleuromutilines such as BC-3781, BC-7013; \n leucyl-t-RNA synthase inhibitors such as AN3365.

Metadata:
- Claim Count in Document: 46.0
- Percentile: 94.0
- Lexical Diversity: 1.16129
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14894408', '14773603', '13989600', '14110818', '14872988']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659918335091893
- 35 USC 102 Novelty (BERT): 0.5863733155391199
- Combined Prediction Score: 0.7480299817121825
- Mean Citation Score: 340.4518700000001
- Max Citation Score: 532.22003
- Similarity Product: 391.105848759762

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test